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Abstract
Background: Bisphenol A (BPA), an commonly exposed environmental chemicals in humans, has been shown to
have a hypercholesterolemic effect with molecular mechanism not clear. Since intestinal cholesterol absorption
plays a major role in maintaining total body cholesterol homeostasis, the present study is to investigate whether
BPA affects cholesterol absorption in the intestinal Caco-2 cells. Methods: The Caco-2 cells were pretreated with
BPA at different concentrations for 24 h and then incubated with radioactive micellar cholesterol for 2 h. The
absorption of radioactive cholesterol was quantified by liquid scintillation. The expression of Niemann-Pick C1-like 1
(NPC1L1) and sterol regulatory element binding protein-2 (SREBP-2) was analyzed by Western blot and qPCR.
Results: We found that confluent Caco-2 cells expressed NPC1L1, and the absorption of cholesterol in the cells was
inhibited by ezetimibe, a specific inhibitor of NPC1L1. We then pretreated the cells with 0.1–10 nM BPA for 24 h
and found that BPA at 1 and 10 nM doses promoted cholesterol absorption. In addition, we found that the BPA-
induced promotion of cholesterol absorption was associated with significant increase in the levels of NPC1L1
protein and NPC1L1 mRNA. Moreover, the stimulatory effects of BPA on cholesterol absorption and NPC1L1
expression could be prevented by blockade of the SREBP-2 pathway.
Conclusions: This study provides the first evidence that BPA promotes cholesterol absorption in the intestinal cells
and the stimulatory effect of BPA is mediated, at least in part, by SREBP-2-NPC1L1 signaling pathway.
Keywords: Bisphenol A, Cholesterol absorption, Caco-2 cells, Niemann-Pick C1-like 1, Sterol regulatory element
binding protein-2, Hypercholesterolemia
Background
Hypercholesterolemia is a significant risk factor for car-
diovascular disease [1]. In addition to denovo cholesterol
synthesis, cholesterol derived from the dietary and bil-
iary cholesterol absorption also contributes to the
amount of cholesterol circulating in plasma [2]. In fact,
the absorption of cholesterol from the intestine is an
important determinant of plasma cholesterol levels [3],
those individuals with high absorption rates are hyper-
cholesterolemic and generally have an increased num-
ber of cardiovascular events [4]. Moreover, inhibition
of cholesterol intestinal absorption leads to lower
cholesterol levels [5].
Cholesterol absorption in intestine is a multi-step
process and this process is mediated by a specific mem-
brane protein named Niemann-Pick C1-like 1 (NPC1L1)
protein [6], which can be specifically inhibited by ezeti-
mibe [7]. NPC1L1 is highly expressed in the small intes-
tine and it is required for intestinal cholesterol
absorption. NPC1L1 knockout mice exhibited an 70%
reduction in cholesterol absorption and were resistant to
diet-induced hypercholesterolemia [6, 8]. Furthermore,
NPC1L1 has been recently identified as a novel target
gene of sterol regulatory element binding protein-2
(SREBP-2) [9]. There are two putative sterol regulatory
elements in the human NPC1L1 promoter and they are
essential for mediating the effects of cholesterol on
promoter activity [9].
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Bisphenol A (BPA) is a man-made compound highly
prevalent in our environment and suspected to act as an
endocrine disruptor [10]. It is intensively produced and
used as a monomer of polycarbonate plastics and epoxy
resins [11]. The human population is widely exposed to
low levels of BPA, primarily by way of the diet by migration
from food and beverage containers [11]. Biomonitoring
surveys have demonstrated that detectable levels of BPA
are present in the urine of nearly all sampled adults in U.S.
population [12]. The ability of BPA to cause adverse
human health effects is highly documented [13–15]. Many
experimental and epidemiological studies highlighted po-
tential links between BPA exposure and the development
of cancer and disorders of reproductive, neuroendocrine,
and immune systems [14, 16]. Recent epidemiological and
animal studies have suggested that circulating BPA levels
are associated with prevalence of coronary heart diseases
and a number of cardiovascular risk factors such as hyper-
cholesterolemia [17–19]. Several in vivo studies have
shown that BPA exposure increased plasma total choles-
terol and low density lipoprotein cholesterol levels [20, 21].
However, the molecular mechanism underlying the hy-
percholesterolemic effects are still unknown. Since the
intestine plays a major role in maintaining total body
cholesterol homeostasis, we, in the present study,
addressed a question whether BPA affects the choles-
terol absorption in the enterocytes.
Methods
Reagents
BPA and dimethyl sulfoxide (DMSO) were purchased
from Sigma-Aldrich (St. Louis, MO, USA). The Dulbecco’s
modified Eagle’s medium (DMEM), M199 medium, heat-
inactivated fetal bovine serum (FBS),1% non-essential
amino acids, and other materials were purchased from
either Invitrogen (Carlsbad, CA, USA) or Sigma-Aldrich
(St. Louis, MO, USA). [14C]cholesterol (50 mCi/mmol)
was purchased from American Radiolabeled Chemicals
Inc (St. Louis, MO, USA) and NPC1L1 antibody from
Santa Cruz (Santa Cruz, CA, USA). cDNA synthesis kit
was purchased from Invitrogen Life Technology (Carlsbad,
CA, USA) and SYBR Green-based real-time PCR kit was
obtained from Applied Biosystems (Foster City, CA,USA).
All other chemicals, unless otherwise indicated, were
purchased from Sigma-Aldrich (St. Louis, MO, USA).
Cell culture and cholesterol absorption assay
Caco-2 cells were obtained from American Tissue Culture
Collection (Virginia, USA) and were cultured in DMEM,
containing 10% FBS, 1% penicillin-streptomycin, 2 mM L-
glutamate, and 1% non-essential-amino acids to 100%
confluence. Before the experiment of cholesterol absorp-
tion, the cells were firstly cultured in medium containing
the delipidized FBS for 24 h as described [22]. Then the
cells were washed three times with M199 buffer and incu-
bated with fresh medium containing the cholesterol mi-
celles for 2 h. The micellar cholesterol solutions were
prepared as in our previous publication [22]. After incuba-
tion, the medium was removed, and the cells were washed
three times with ice-cold PBS. The cell pellets were
dissolved in 0.1 M NaOH, and an aliquot of 0.1 ml of the
lysate was taken for liquid scintillation counting.
Effects of BPA on cholesterol absorption
To investigate the effects of BPA on cholesterol absorp-
tion, the cells were pretreated with 0.1–10 nM BPA for
24 h [23]. After the pretreatment, the medium was
removed and the cells were washed three times with ice-
cold PBS, followed by incubation with the cholesterol
micelles as described above. BPA was delivered to the
cells using DMSO solvent, the amount of DMSO added
to the cells was not greater than 0.1% (v/v). The cells
treated with the equal amount of DMSO alone were
taken as controls.
Real-time quantitative PCR
Methods for RNA extraction and real-time quantitative
PCR (qPCR) have been previously described in our pre-
vious publications [22]. The primers used in qPCR to
quantify the mRNA of NPC1L1 and SREBP-2 were
shown in Table 1. GAPDH was amplified as an internal
control.
Western blot analysis
Methods for cell free extract and Western blotting has
been previously described [22, 24]. In brief, 40 μg of
proteins in cell lysate was subjected to 7.5% SDS-PAGE
and transferred to a nitrocellulose membrane electro-
phoretically overnight. The membranes were incubated
with anti-NPC1L1 antibody (1:5000) and then with
second antibody (1:50000) conjugated with horseradish
peroxidase. The specific NPC1L1 bands (145 kD) were
identified by enhanced chemiluminescence advance
reagent. The membranes were then stripped and re-
probed with anti-actin antibody.





SREBP-2-R 5’- AGGATGTCACCAGGCTTTGGAC -3’
GAPDH-F 5’-CATGAGAAGTATGACAACAGCCT-3’
GAPDH-R 5’-AGTCCTTCCACGATACCAAAGT-3’
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RNA interference
SREBP-2 expression was knocked down by transfection
of human SREBP-2 small interfering RNA (siRNA) with
Caco-2 cells. A nonrelated, scrambled siRNA was used
as a control. Transfection reagent and all siRNA oligos
were designed and synthesized by Dharmacon. Transfec-
tions were carried out according to the manufacturer’s
protocol using the DharmaFECT Reagent 4.
Statistical analysis
The results are presented as mean ± S.E.M. Statistical
analyses were performed using one-way analysis of
variance (ANOVA) followed by the Bonferroni posttest
for multiple comparisons. Differences were considered
significant at P < 0.05.
Results
Absorption of cholesterol in Caco-2 cells was mediated by
NPC1L1
Because the cholesterol absorption in intestine was me-
diated by NPC1L1 and ezetimibe is a specific inhibitor
for NPC1L1, we first examined whether the Caco-2 cells
express NPC1L1 and whether cholesterol absorption in
Caco-2 cells under the experimental conditions was
related to the functions of NPC1L1. As shown in Fig. 1a,
Western blot analysis clearly demonstrated the expres-
sion of NPC1L1 protein in these cells. In addition, the
cholesterol absorption was dose-dependently inhibited
by ezetimibe (Fig. 1b).
BPA promoted cholesterol absorption in Caco-2 cells
We then addressed a question whether BPA can pro-
mote cholesterol absorption. Caco-2 cells were pre-
treated with 10 nM BPA for 3 h, 6 h and 24 h or
pretreated with different concentrations of BPA for 24 h,
then the amount of cholesterol absorption by the cells
was then measured. The time-dependent effect of BPA
on cholesterol absorption is presented in Fig. 2a, the
results showed that the absorption of [14C] cholesterol
was increased with the treantment time linearly and up
to 24 h. Results from concentration dependent stimula-
tion studies with BPA on the cellular absorption of [14C]
cholesterol following 24 h of treatment are presented in
Fig. 2b. As illustrated in this figure, there was no signifi-
cant change in the cellular absorption of [14C] choles-
terol in the presence of 0.1 nM of BPA (P > 0.05). The
stimulatory effect of BPA started at concentrations ≥ 1
nM in a concentration dependent manner. The cellular
absorption of cholesterol was significantly higher in the
presence of 1 and 10 nM of BPA (P < 0.05) compared to
control cells in the absence of BPA.
BPA promoted NPC1L1 protein and mRNA expression
To elucidate the molecular mechanism by which BPA
promoted cholesterol absorption in Caco-2 cells, we then
further analyzed the impact of BPA on NPC1L1 expres-
sion in the intestinal cells. After pretreating the cells with
different concentrations of BPA for 24 h, the protein and
mRNA expression of NPC1L1 were evaluated by Western
blot and real-time PCR, respectively. As shown in Fig. 3a,
pretreatment of the cells with BPA significantly increased
NPC1L1 protein expression. No similar changes could be
identified for the levels of β-actin. Simultaneously, the
mRNA expression of NPC1L1 was dose-dependently in-
creased by BPA, as normalized with that of control gene
GAPDH (Fig. 3b). Furthermore, to address that the stimu-
latory effect of bisphenol A on cholesterol absorption is
solely mediated by NPC1L1, we used NPCIL1 inhibitor
ezetimibe to block NPC1L1 and found that the en-
hanced cholesterol absorption induced by bisphenol A
was markedly attenuated (Fig. 3c).
The SREBP-2 may be involved in the BPA-induced promotion
of NPC1L1 expression and cholesterol absorption
Since the expression of NPC1L1 is regulated by SREBP-
2, we then wanted to know whether SREBP-2 could be
Fig. 1 Cholesterol absorption by Caco-2 cells is mediated by
NPC1L1. a The expression of NPC1L1 in Caco-2 cells. The cells were
cultured to 100% confluence. The cellular protein was extracted and
subjected to Western blot analysis for the expression of NPC1L1 and
β-actin. b The cells were pretreated with ezetimibe at different
concentrations for 2 h and then incubated with radioactive micellar
cholesterol for 2 h. The absorption of cholesterol in the absence of
ezetimibe was normalized to 100%. Results are mean ± SEM of three
separate determinations. *P < 0.05, **P < 0.01
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involved in our observed NPC1L1 up-regulation. After
pretreating the cells with BPA for 24 h, we found that
the expression of SREBP-2 was dose-dependently up-
regulated (Fig. 4a). We next examined the effects of the
knockdown of SREBP-2 by small interfering RNA trans-
fection on BPA-mediated NPC1L1 expression and chol-
esterol absorption. When SREBP-2 was suppressed by
the specific RNA interference, no effect of BPA on
NPC1L1 expression could be detected (Fig. 4b), and no
significant increase of micellar cholesterol absorption by
BPA in Caco-2 cells could be identified (Fig. 4c).
Discussion
The findings of our present study demonstrate for the
first time that BPA at environmentally relevant doses
promotes cholesterol absorption in the intestinal cells
and the stimulatory effect of BPA is mediated, at least in
part, by SREBP-2-NPC1L1 signaling pathway.
BPA is an environmental chemical used as a constitu-
ent monomer in polycarbonate plastics, which are used
extensively in drinks containers and food packaging, and
in the production of oxidants used in the lining of
canned goods [11]. Exposure to BPA is believed to be
Fig. 2 The effect of BPA on micellar cholesterol absorption in Caco-2 cells. a Time-dependent effect of BPA on cholesterol absorption in Caco-2 cells.
The cells were pretreated with 10 nM BPA for different time, and then incubated with radioactive micellar cholesterol for 2 h. b Dose-dependent effect
of BPA on cholesterol absorption in Caco-2 cells. The cells were pretreated with BPA at different concentrations for 24 h, and then incubated with
radioactive micellar cholesterol for 2 h. The absorption of cholesterol was determined and that in the absence of BPA was taken as 100%. Results are
mean ± SEM from triplicate determinations in three separate experiments. *P < 0.05 compared to untreated cells (Control)
Fig. 3 The effect of BPA on NPC1L1 expression in Caco-2 cells. a The cells were treated with BPA at different concentrations for 24 h, and the
whole-cell lysates were analyzed by Western blot. The results are representative of three independent experiments. b NPC1L1 mRNA abundance
was determined by real-time RT-PCR as described in Methods. Expression values were normalized to housekeeping genes, and expression in
untreated cells was set to 1. Values shown represent means ± SEM of three independent experiments, *P < 0.05, **P < 0.01, compared to untreated
cells. c After the blockade of NPC1L1 expression by ezetimibe(EZE), Caco-2 cells were incubated with BPA for 24 h, then incubated with
radioactive micellar cholesterol for additional 2 h. The absorption of cholesterol in the absence of BPA was normalized to 100%. Results are
mean ± SEM from triplicate determinations in three separate experiments. *P < 0.05 compared to untreated cell
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mainly through dietary intake with additional exposure
through water, dental sealants, inhalation of household
dusts, and exposure through skin [11]. A lot of studies
have documented widespread human exposure to BPA
[12]. Levels of BPA ranging from 0.3 to 5 ng/mL (~1–20
nM) are present in adult and fetal human plasma, urine,
and breast milk [25]. BPA, a lipophilic compound, can
accumulate in fat, with detectable levels found in 50% of
breast adipose tissue samples from women [26]. BPA
expoure has been reported to cause adverse human
health effects such as cancer, reproductive, neuroendo-
crine, and immune systems disorders [13, 14, 16]. Add-
itionally, several lines of recent evidence suggest that an
association between circulating BPA levels and hyper-
cholesterolemia, studies in animals and humans have
also shown that BPA exposure increased cholesterol
levels in blood [19–21], but the molecular mechanisms
underlying the hypercholesterolemic effects of BPA are
still unkown. Since the intestine plays a major role in
maintaining total body cholesterol homeostasis, and
human exposure to BPA is primarily through dietary in-
take, whether absorption of cholesterol in the entero-
cytes can be affected by BPA is therefore an important
question to be studied. Our results for the first time
show that BPA at environmentally relevant doses has
stimulatory effects on cholesterol absorption in the intes-
tinal cells. The conclusion is supported by the following
evidence. First, the Caco-2 cells used in our experiments
expressed NPC1L1 and the absorption of cholesterol in
our system was mainly mediated by NPC1L1. Second,
pretreatment of the cells with BPA significantly promoted
cholesterol absorption, which was accompanied by an
increase of NPC1L1 protein and mRNA expression.
Exposure of humans to BPA is ubiquitous at low
levels(~1–20 nM), the dose used in the present study is
environmentally relevant and our research may have
clinical implication. Several studies have revealed that
exposure to environmentally relevant BPA doses could
alter various biological functions, including reproductive,
behavioral, metabolic, and immune systems [16]. Hugo
et al. has shown that BPA at environmentally relevant
doses inhibits the release of a key adipokine that pro-
tects humans from metabolic syndrome [23], which may
be one mechanism that is responsible for the metabolic
disorders and obesity caused by BPA. Furthermore, our
results also potentially suggest a new mechanism that is
responsible for the hypercholesterolemic effects of BPA.
It is noted that the liver is also important for systemic
Fig. 4 The promotion of BPA on NPC1L1 expression and cholesterol absorption may be mediated through SREBP-2. a Expression analysis of
SREBP-2 in Caco-2 cells after 24 h of stimulation with increasing concentrations of BPA. Data are presented as means ± SEM of three independent
experiments. *P < 0.05, ***P < 0.001 compared to untreated cells. b Up-regulation of NPC1L1 expression in Caco-2 cells after 24 h incubation with
BPA, by transfecting short interfering RNA (siRNA) for SREBP-2 compared with scramble control transfections. Data are presented as means ± SEM
of three independent experiments. *P < 0.05 compared to untreated cells. c After the inhibition of SREBP-2 expression using siRNA, Caco-2 cells
were incubated with BPA for 24 h, then incubated with radioactive micellar cholesterol for additional 2 h. The absorption of cholesterol in the
absence of BPA was normalized to 100%. Results are mean ± SEM from triplicate determinations in three separate experiments. **P < 0.01
compared to untreated cell
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lipid metabolism and is the primary target organ of BPA.
A recent study in mice has shown that BPA exposure
significantly increased the expression levels of genes re-
lated to lipid synthesis such as HMG-CoA reducase, the
key enzyme responsible for cholesterol synthesis in liver
[27]. Take together, there results indicate that BPA can
increase the cholesterol levels by two mechanisms, one
in the intestine to enhance the absorption via NPC1L1
transporter, and the other in the liver to increase the
synthesis by HMG-CoA reducase.
NPC1L1 is a crucial transporter for cholesterol absorp-
tion [6]. Understanding the regulation of its expression
is of importance in human health and disease. Recent
studies have shown the increase in NPC1L1 expression
in hypercholesterolemia associated with diseases such as
diabetes mellitus [28, 29]. Moreover, NPC1L1 inhibition
or deficiency was shown to protect against diet-induced
hypercholesterolemia and hepatic steatosis [30, 31].
Since NPC1L1 plays a pivotal role in mediating intestinal
cholesterol absorption and the processes of cholesterol
homeostasis, we argued that BPA may directly influence
its function. In our studies, we found that pretreatment
of the cells with BPA significantly increased NPC1L1
mRNA and protein levels, and the changes in cholesterol
absorption consistently corresponded to the changes in
NPC1L1 mRNA and protein expression. Moreover, to ad-
dress that the stimulatory effect of bisphenol A on choles-
terol absorption is solely mediated by NPC1L1, we further
used NPCIL1 inhibitor ezetimibe to block NPC1L1 and
found that the enhanced cholesterol absorption induced
by bisphenol A was markedly attenuated. These results
suggest the mechanism may involve an increase in choles-
terol absorption due to a up-regulation of NPC1L1, thus
contributing to the hypercholesterolemic effect of BPA.
Regarding the molecular signals regulating the intes-
tinal expression of NPC1L1, we found that expression of
the transcription factor SREBP-2 is involved in BPA-
induced up-regulation of NPC1L1. It is known that the
expression of NPC1L1 is mainly regulated by transcrip-
tion factor SREBP-2. There are two putative sterol regu-
latory elements in the human NPC1L1 promoter [9],
and the expression of NPC1L1 gene can be up-regulated
by SREBP-2 activation in the intestine [9]. Moreover,
BPA has been found to induce liver SREBP-2 expression
in mice [20, 32]. Thus, we hypothesized that BPA influ-
enced NPC1L1 expression presumably through the
SREBP-2-mediated signal transduction pathway. In sup-
porting this hypothesis, when Caco-2 cells were stimu-
lated with BPA, we did find significantly increased
expression of the SREBP-2 in the cells, and when
SREBP-2 was depleted by siRNA, NPC1L1 expression
was no longer increased by BPA, and no increase in mi-
cellar cholesterol absorption was observed. Our studies
demonstrate that BPA modulates intestinal NPC1L1
expression at both transcriptional and translational regu-
lations and the SREBP-2 transcription factor may be
critically involved in such regulations.
Furthermore, with regard to the mechanism by which
BPA up-regulated the expression of SREBP-2, the epi-
genetic regulation may be involved. It is known that pro-
moter methylation levels tend to relate negatively to
gene expression. Ke et al. has recently shown that the
promoters of SREBP-2 and HMG-CoA reducase were
hypomethylated in the BPA-exposed mice, which is very
likely to contribute to the promoted transcription of
SREBP-2 and its targets. Because DNA methyltransferase
knockdown led to the promoter hypomethylation and
increased mRNA expression of SREBP-2 and HMG-CoA
reducase [27]. These results indicated that SREBP-2 was
up-regulated by BPA via reprogramming the DNA
methylation patterns.
Conclusions
In conclusion, our current results imply a potential role of
BPA, at environmentally relevant concentrations that can
be detected in vivo, in stimulating intestinal cholesterol
absorption and in promoting hypercholesterolaemia. The
mechanisms may be involved in SREBP-2 activation and
subsequent up-regulation of NPC1L1 expression.
Abbreviations
BPA: Bisphenol A; DMEM: Dulbecco’s modified Eagle’s medium;
DMSO: Dimethyl sulfoxide; FBS: Fetal bovine serum; NPC1L1: Niemann-Pick
C1-like 1; qPCR: quantitative PCR; siRNA: short interfering RNA; SREBP-2: Sterol
regulatory element binding protein-2
Acknowledgements
We thank Dr. Duan RD in Lund University, Sweden, for the ezetimibe
providing and for valuable suggestions.
Funding
This work was supported by grants from the National Natural Science
Foundation of China (81402674) and the Young Teachers’ Training Project of
Sun Yat-sen University (16ykpy11). Dan Feng is the grant recipient and is
involved in the design and organization of the study, interpretation of the
results, and the preparation of the manuscript.
Availability of data and materials
Data sharing not applicable to this article as no datasets were generated or
analysed during the current study.
Authors’ contributions
SSZ, XCL, PYL and MQL are involved in the bench work, data acquisition and
analysis. JZ is involved in the cholesterol absorption assay and manuscript
preparation. DF is involved in the design and organization of the study,
interpretation of the results, and the preparation of the manuscript. All
authors have read and approved the final manuscript.
Competing interests




1Guangdong Provincial Key Laboratory of Food, Nutrition and Health,
Department of Preventive Medicine, School of Public Health, Sun Yat-sen
Feng et al. Lipids in Health and Disease  (2017) 16:2 Page 6 of 7
University (Northern Campus), 74 Zhongshan Road 2, Guangzhou,
Guangdong Province 510080, China. 2Department of Cardiology, Affiliated
NanHai Hospital of Southern Medical University, Foshan 528200, China.
Received: 6 October 2016 Accepted: 15 December 2016
References
1. Weingartner O, Lutjohann D, Bohm M, Laufs U. Cholesterol homeostasis and
cardiovascular risk. Dtsch Med Wochenschr. 2011;136:34–8.
2. Howles PN. Cholesterol absorption and metabolism. Methods Mol Biol.
2016;1438:177–97.
3. Kruit JK, Groen AK, van Berkel TJ, Kuipers F. Emerging roles of the intestine in
control of cholesterol metabolism. World J Gastroenterol. 2006;12:6429–39.
4. Stitziel NO, Won HH, Morrison AC, Peloso GM, Do R, et al. Inactivating
mutations in NPC1L1 and protection from coronary heart disease.
N Engl J Med. 2014;371:2072–82.
5. Smith BA, Wright C, Davidson M. Role of Ezetimibe in lipid-lowering and
cardiovascular disease prevention. Curr Atheroscler Rep. 2015;17:72.
6. Altmann SW, Davis Jr HR, Zhu LJ, Yao X, Hoos LM, et al. Niemann-Pick C1
Like 1 protein is critical for intestinal cholesterol absorption. Science. 2004;
303:1201–4.
7. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, et al. The target of
ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci US A.
2005;102:8132–7.
8. Davis Jr HR, Hoos LM, Tetzloff G, Maguire M, Zhu LJ, et al. Deficiency of
Niemann-Pick C1 Like 1 prevents atherosclerosis in ApoE-/- mice.
Arterioscler Thromb Vasc Biol. 2007;27:841–9.
9. Alrefai WA, Annaba F, Sarwar Z, Dwivedi A, Saksena S, et al. Modulation of
human Niemann-Pick C1-like 1 gene expression by sterol: Role of sterol
regulatory element binding protein 2. Am J Physiol Gastrointest Liver
Physiol. 2007;292:G369–76.
10. Corrales J, Kristofco LA, Steele WB, Yates BS, Breed CS, et al. Global
assessment of bisphenol A in the environment: review and analysis of its
occurrence and bioaccumulation. Dose Response. 2015;13:
1559325815598308.
11. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human
exposure to bisphenol A (BPA). Reprod Toxicol. 2007;24:139–77.
12. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S.
population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ
Health Perspect. 2008;116:39–44.
13. Rezg R, El-Fazaa S, Gharbi N, Mornagui B. Bisphenol A and human chronic
diseases: current evidences, possible mechanisms, and future perspectives.
Environ Int. 2014;64:83–90.
14. Rochester JR. Bisphenol A, and human health: a review of the literature.
Reprod Toxicol. 2013;42:132–55.
15. Srivastava S, Gupta P, Chandolia A, Alam I. Bisphenol A: a threat to human
health? J Environ Health. 2015;77:20–6.
16. Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE,
et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod
Toxicol. 2007;24:199–224.
17. Melzer D, Osborne NJ, Henley WE, Cipelli R, Young A, et al. Urinary
bisphenol A concentration and risk of future coronary artery disease in
apparently healthy men and women. Circulation. 2012;125:1482–90.
18. Kim MJ, Moon MK, Kang GH, Lee KJ, Choi SH, et al. Chronic exposure to
bisphenol A can accelerate atherosclerosis in high-fat-fed apolipoprotein E
knockout mice. Cardiovasc Toxicol. 2014;14:120–8.
19. Olsen L, Lind L, Lind PM. Associations between circulating levels of
bisphenol A and phthalate metabolites and coronary risk in the elderly.
Ecotoxicol Environ Saf. 2012;80:179–83.
20. Marmugi A, Lasserre F, Beuzelin D, Ducheix S, Huc L, et al. Adverse
effects of long-term exposure to bisphenol A during adulthood leading
to hyperglycaemia and hypercholesterolemia in mice. Toxicology.
2014;325:133–43.
21. Moghaddam HS, Samarghandian S, Farkhondeh T. Effect of bisphenol A on
blood glucose, lipid profile and oxidative stress indices in adult male mice.
Toxicol Mech Methods. 2015;25:507–13.
22. Zou J, Feng D. Lycopene reduces cholesterol absorption through the
downregulation of Niemann-Pick C1-like 1 in Caco-2 cells. Mol Nutr Food Res.
2015;59:2225–30.
23. Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, et al. Bisphenol
A at environmentally relevant doses inhibits adiponectin release from
human adipose tissue explants and adipocytes. Environ Health Perspect.
2008;116:1642–7.
24. Feng D, Ohlsson L, Duan RD. Curcumin inhibits cholesterol uptake in Caco-2
cells by down-regulation of NPC1L1 expression. Lipids Health Dis. 2010;9:40.
25. Welshons WV, Nagel SC, vom Saal FS. Large effects from small exposures. III.
Endocrine mechanisms mediating effects of bisphenol A at levels of human
exposure. Endocrinology. 2006;147:S56–69.
26. Fernandez MF, Arrebola JP, Taoufiki J, Navalon A, Ballesteros O, et al.
Bisphenol-A and chlorinated derivatives in adipose tissue of women.
Reprod Toxicol. 2007;24:259–64.
27. Ke ZH, Pan JX, Jin LY, Xu HY, Yu TT, et al. Bisphenol A exposure may induce
hepatic lipid accumulation via reprogramming the DNA methylation
patterns of genes involved in lipid metabolism. Sci Rep. 2016;6:31331.
28. Lally S, Owens D, Tomkin GH. Genes that affect cholesterol synthesis,
cholesterol absorption, and chylomicron assembly: the relationship between
the liver and intestine in control and streptozotosin diabetic rats.
Metabolism. 2007;56:430–8.
29. Lally S, Tan CY, Owens D, Tomkin GH. Messenger RNA levels of genes
involved in dysregulation of postprandial lipoproteins in type 2 diabetes:
the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5
and G8, and of microsomal triglyceride transfer protein. Diabetologia.
2006;49:1008–16.
30. Davies JP, Scott C, Oishi K, Liapis A, Ioannou YA. Inactivation of NPC1L1
causes multiple lipid transport defects and protects against diet-induced
hypercholesterolemia. J Biol Chem. 2005;280:12710–20.
31. Deushi M, Nomura M, Kawakami A, Haraguchi M, Ito M, et al. Ezetimibe
improves liver steatosis and insulin resistance in obese rat model of
metabolic syndrome. FEBS Lett. 2007;581:5664–70.
32. Marmugi A, Ducheix S, Lasserre F, Polizzi A, Paris A, et al. Low doses of
bisphenol A induce gene expression related to lipid synthesis and trigger
triglyceride accumulation in adult mouse liver. Hepatology. 2012;55:395–407.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Feng et al. Lipids in Health and Disease  (2017) 16:2 Page 7 of 7
